Researchers at Stanford Medicine have pulled off something that seemed impossible just a few years ago: they've reversed Type 1 diabetes in mice without insulin injections or immune-suppressing medications. The trick was getting the immune system to stop attacking itself—a kind of biological reset.
Type 1 diabetes happens when the immune system goes rogue and destroys the insulin-producing cells in the pancreas. The Stanford team's approach was to transplant both blood stem cells and insulin-producing pancreatic cells from a donor, combined with a pre-treatment regimen that included targeted antibodies and low-dose radiation. The result: the recipient's immune system learned to coexist with the new cells. Over six months, treated mice stayed healthy without needing insulin or immunosuppressive drugs.
"The key steps in our study—which result in animals with a hybrid immune system containing cells from both the donor and the recipient—are already being used in the clinic for other conditions," said Seung K. Kim, MD, PhD, the senior author and director of the Stanford Diabetes Research Center. That matters because it means the pieces of this puzzle already exist in clinical practice.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxHow the immune system learns
The elegance of this approach lies in what happens after transplantation. The donated blood stem cells essentially re-educate the recipient's immune system. Instead of attacking everything foreign—or attacking its own cells—the hybrid immune system learns to accept both the donor's new islet cells and the recipient's healthy tissues. At the same time, the donor cells learn not to attack the recipient's body, avoiding a dangerous complication called graft-versus-host disease.
Graduate student Preksha Bhagchandani and postdoctoral fellow Stephan Ramos added one key modification to previous protocols: an autoimmune-targeting drug. That small change made all the difference. In the experiment, 19 out of 19 mice were prevented from developing Type 1 diabetes, and nine out of nine mice that already had long-standing diabetes were cured.
This builds on decades of work showing that bone marrow transplants from partially matched donors could create similar hybrid immune systems in humans. In some cases, transplanted kidneys from those same donors functioned for decades without rejection drugs.
The gap between mice and humans
Several hurdles remain before this reaches human patients. Pancreatic islets can only be harvested after donor death, and the timing has to align with available blood stem cells. It's also unclear whether the number of islet cells from a single donor would be enough to reverse established Type 1 diabetes in adults.
The Stanford team is already working on solutions. They're exploring ways to generate large quantities of islet cells in the lab from pluripotent stem cells, and researching how to boost the function and survival of transplanted cells. Beyond diabetes, the gentler pre-conditioning approach could potentially treat other autoimmune diseases like rheumatoid arthritis and lupus, as well as sickle cell anemia and mismatched organ transplants.
The study, published in November in the Journal of Clinical Investigation, represents a meaningful step toward a future where the immune system can be safely reset—not just for diabetes, but for a range of diseases where the body's defense system has gone wrong.
